Elpro International Acquires Laurus Labs for INR 10.00 Crores

Elpro International Ltd. has acquired 2,02,040 Equity Shares of Laurus Labs Limited, a research-driven pharmaceutical manufacturing organization. The acquisition was made for a consideration of INR 10.00 Crores. Laurus Labs, established in 2005, is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, with a strong market position in therapeutic areas including anti-retroviral (ARV), oncology, cardiovascular, and gastroenterology. The company has a net worth of Rs. 4,207.05 as on March 31, 2024, and a profit after tax of Rs. 223.70 as on March 31, 2024. The standalone turnover of the last three financial years is 4,812.39 Crores (FY 2023-24), 5,773.45 Crores (FY 2022-23), and 4,707.04 Crores (FY 2021-22). Laurus Labs has a presence in India, Germany, and the UK.